KYTHERA Acquires Worldwide Rights to Clinical Compound and Key Intellectual Property for Potential Novel Treatment of Hair Loss

Go back to KYTHERA Acquires Worldwide Rights to Clinical Compound and Key Intellectual Property for Potential Novel Treatment of Hair Loss
KYTHERA BIOPHRM (NASDAQ: KYTH) Delayed: 74.98 --0 (-0%)
Previous Close $74.98    52 Week High $76.31 
Open $0.03    52 Week Low $29.86 
Day High $74.98    P/E N/A 
Day Low $74.98    EPS $-3.35 
Volume 6,650